Growth and Integration of ML/AI in Biotech

by | Jun 8, 2021 | AI, Digital Health, MedTech, ML, Quality

The biotechnology and pharmaceutical industries are heavily reliant on collecting, storing, and analyzing data for both R&D as well as production purposes. The large, countless, and rapidly growing sets of data are critical for researchers and scientists to accelerate progress in the medical industry. As our technologies advance and our capacity to store data continue to increase, we must continue to find new ways to efficiently analyze data. Researchers at the European Bioinformatics Institute (EMBL-EBI) have determined that nucleotide and proteomics data is growing at an exponential rate, with the amount of data stored on their servers doubling each year 1. Although larger data sets may indicate an abundance of opportunities for researchers, the challenge is in effectively analyzing and processing the data. This is where Artificial Intelligence and Machine Learning (AI/ML) can be utilized to take on the challenge. AI is a concept in which we create intelligent machines and systems, and ML is an application of AI in which machines and systems can learn and analyze data without being ‘told to do so’ 2.

As software and applications utilizing AI/ML are continuously being implemented into different medical devices and systems, the need to regulate these software’s is a pressing issue. The FDA is changing its stance on how it reviews and regulates biomedical devices employed with AI/ML software. We can expect a shift in the FDA’s stance on AI/ML software-based devices as the software will be the critical functioning aspect of a device – rather than its physical mechanics or chemistry. 3 The growing need for regulatory affairs and intervention in these devices requires a high level of quality assurance to ensure that any issued software for systems and devices is compliant with the FDA and cGMPs.

EMMA International is here to provide full-circle solutions for all aspects of the MedTech industry. Give us a call at 248-987-4497 or email us at info@emmainternational.com to learn more about how EMMA International can take the stress out of quality and regulatory compliance!

1 Oliveira, A.L. (2019), Biotechnology, Big Data and Artificial Intelligence. Biotechnol. J., 14: 1800613. https://doi.org/10.1002/biot.201800613

2 UIC (Nov. 2020) Machine Learning in Healthcare: Examples, Tips & Resources for Implementing into Your Care Practice. https://healthinformatics.uic.edu/blog/machine-learning-in-healthcare/

3 FDA (Jan. 2021) Artificial Intelligence and Machine Learning in Software as a Medical Device. https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-software-medical-device

Kareem Arafat

Kareem Arafat

Quality Engineer- Mr. Arafat has experience in combination products, pharmaceuticals, and FDA compliance for many life science industries. He has experience with many different elements of quality and regulatory compliance. Mr. Arafat holds a Bachelor of Science in Materials Science & Engineering from Michigan State University.

More Resources

The End of the COVID-19 Public Health Emergency

The End of the COVID-19 Public Health Emergency

After over 3 years, the COVID-19 Public Health Emergency (PHE) will end on May 11, 2023, the Biden Administration announced last week.1After 3.5 years of the modified policy to allow for amore efficient path for COVID-19-related medical products to get to market, this begs the question of how it will impact the MedTech world.
Process Validation

Process Validation

All right, you have just gotten all of your paperwork together, submitted the right forms to the right people, set up your factory, hired and trained your staff; now it’s time to make the medical devices. The regulatory nonsense is over and done, right?
The Role of Management in Product Quality

The Role of Management in Product Quality

Depending on the factory, some production employees may find it surprising that management has an important role to play in a quality system.  21 CFR 820.20 mandates that “Management with executive responsibility shall establish objectives for, and commitment to, quality”.[1]  The Federal Government expects that management takes an active interest in improving the output of their company, at least in the case of medical device manufacturers.

Ready to learn more about working with us?

Pin It on Pinterest

Share This